[1] 中华人民共和国国家卫生健康委员会.新型冠状病毒肺炎诊疗方案(试行第七版) [EB/OL].(2020-03-04)
[2] 中华人民共和国国家卫生健康委员会. 关于修订新型冠状病毒肺炎英文命名事宜的通知[EB/OL]. (2020-02-21)[2020-03-08].
[3] 中华人民共和国国家卫生健康委员会. 关于印发新型冠状病毒感染的肺炎诊疗方案(试行第三版)的通知[EB/OL].(2020-01-23)[2020-03-08].
[4] 中华人民共和国国家卫生健康委员会. 关于印发新型冠状病毒感染的肺炎诊疗方案(试行第五版)的通知[EB/OL].(2020-02-04)[2020-03-08].
[5] XU X W, WU X X, JIANG X G, et al. Clinical findings in a group of patients infected with the 2019 novel corona virus (SARS-CoV-2) outside of Wuhan,China:retrospective case series[J]. BMJ, 2020, 368: m606.
[6] CHEN N, ZHOU M, DONG X, et al. Epidemiological and Clinical Characteristics of 99 Cases of 2019 Novel Coronavirus Pneumonia in Wuhan, China: A Descriptive Study[J]. Lancet, 2020,395(10 223):507-513. |
| [1] |
. [J]. 滨州医学院学报, 2020, 43(4): 309-311. |
| [2] |
WANG Peng, LI Li. The clinical efficacy of bevacizumab combined with pemetrexed in the maintenance treatment of advanced lung adenocarcinoma[J]. 滨州医学院学报, 2020, 43(3): 186-189. |
| [3] |
. [J]. 滨州医学院学报, 2020, 43(3): 239-240. |
| [4] |
. [J]. 滨州医学院学报, 2020, 43(2): 152-153. |
| [5] |
. [J]. 滨州医学院学报, 2020, 43(1): 75-77. |
| [6] |
QIU Teng, HU Xiaotao. Clinical effect and adverse reaction analysis of TURP combined with endocrine therapy for advanced prostate cancer[J]. 滨州医学院学报, 2019, 42(6): 421-423. |
|
|
|
|
